NASDAQ: SNOASonoma Pharmaceuticals Inc Stock Ownership - Who owns Sonoma Pharmaceuticals?
Insider buying vs selling
Have Sonoma Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SNOA insiders and whales buy or sell their stock.
SNOA Shareholders
What type of owners hold Sonoma Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Robert Burlingame | 80.14% | 1,294,931 | $2.98M | Insider |
| Hojabr Alimi | 63.81% | 1,031,050 | $2.37M | Insider |
| Akihisa Akao | 32.33% | 522,414 | $1.20M | Insider |
| Bruce Thornton | 9.56% | 154,411 | $355.15k | Insider |
| Amy Moss Trombly | 9.51% | 153,586 | $353.25k | Insider |
| Richard K. Conley | 7.59% | 122,650 | $282.10k | Insider |
| Robert E. Miller | 6.72% | 108,536 | $249.63k | Insider |
| Jerome J. Dvonch | 5.24% | 84,595 | $194.57k | Insider |
| Gregory M. French | 5.04% | 81,510 | $187.47k | Insider |
| Jay E. Birnbaum | 3.20% | 51,659 | $118.82k | Insider |
SNOA vs Pharmaceutical Stocks
Sonoma Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.